Pediatric Asthma Treatment Global Market Report 2025
상품코드:1810994
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소아천식 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.4%로 143억 9,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 소아 알레르기 질환의 유병률 증가, 중증 소아 천식에 대한 생물학적 치료의 확대, 소아 약물 개발에 대한 투자 증가, 맞춤형 의료 및 정밀의료에 대한 관심 증가, 민간 의료 서비스를 이용할 수 있는 중산층 인구 증가 등에 기인하는 것으로 보입니다. 이 기간 중 예상되는 주요 동향으로는 소아 친화적인 생물제제의 개발, 신속한 알레르겐 식별 툴의 개발, 전자건강기록의 통합, 흡입제제의 혁신, 천식 면역 치료의 발전 등이 있습니다.
호흡기 감염증의 유병률 증가는 향후 소아 천식 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 호흡기 감염은 코, 목, 기도, 폐 등 호흡기에 영향을 미치는 바이러스, 세균, 기타 병원균에 의해 발생하는 질병입니다. 미세먼지나 이산화질소와 같은 오염물질에 노출되면 호흡기가 약해져 감염성 질환에 걸리기 쉽기 때문입니다. 소아 천식 치료는 기도 기능을 개선하고 염증을 억제하여 호흡기 감염의 빈도와 중증도를 낮추고, 감염을 유발하는 요인을 줄입니다. 예를 들어 호주 정부 기관인 Australian Institute of Health and Welfare에 따르면 만성폐쇄성폐질환은 전체 질병 부담의 3.6%를 차지하며, 2023년에는 호흡기 질환의 전체 부담의 50%를 차지할 것으로 예측됩니다. 또한 호주에서는 2022년에 약 63만 8,000명(인구의 2.5%)이 만성폐쇄성폐질환을 앓고 있는 것으로 추산됩니다. 따라서 호흡기 감염증의 발병률 증가가 소아 천식 치료제 시장의 성장을 가속하고 있습니다.
소아 천식 치료제 시장의 주요 기업은 소아 호흡기 염증을 표적화하여 억제하는 모노클로널 항체 등 혁신적 치료법에 집중하고 있습니다. 모노클로널 항체는 특정 세포나 물질을 특이적으로 표적화하여 유해한 병원균과 싸우는 면역계의 능력을 모방하도록 설계된 실험실에서 생산되는 단백질입니다. 예를 들어 2024년 4월 영국 제약 및 생명공학 기업 아스트라제네카(AstraZeneca PLC)는 미국 식품의약국(FDA)으로부터 호산구성 표현형을 특징으로 하는 6-11세 중증 천식 환아를 위한 추가 유지 치료제로 파센라(Fasenla, 벤라리주맙)를 승인받았습니다. 이 항체는 호산구를 표적으로 제거함으로써 천식 악화를 억제하고 증상 조절을 개선하는 것을 목적으로 합니다. 파센라는 처음 3회는 4주에 1회, 이후 8주에 1회 피하주사로 투여하며, 소아에게는 체중을 기준으로 투여 횟수를 조절합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 소아천식 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 소아천식 치료 시장 : 성장률 분석
세계의 소아천식 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 소아천식 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 소아천식 치료 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 소아천식 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
장기 관리약
속효성약
기타 유형
세계의 소아천식 치료 시장 : 약제 클래스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
흡입 코르티코스테로이드
장시간 작용형 베타 자극약
류코트리엔 수식약
항히스타민제
생물제제
세계의 소아천식 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 경로
비강 경로
주사 경로
세계의 소아천식 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 소아천식 치료 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어
기타 최종사용자
세계의 소아천식 치료 시장 : 서브 세분화, 장기 관리약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
흡입 코르티코스테로이드
류코트리엔 수식약
장시간 작용형 베타 자극약
복합 흡입기
생물학적 요법
세계의 소아천식 치료 시장 : 서브 세분화, 속효성약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단시간 작용형 베타 자극약
항콜린제
전신성 코르티코스테로이드
세계의 소아천식 치료 시장 : 서브 세분화, 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
면역치료
메틸 크산틴
대체요법
제7장 지역별·국가별 분석
세계의 소아천식 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 소아천식 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
소아천식 치료 시장 : 경쟁 구도
소아천식 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
GlaxoSmithKline plc
Takeda Pharmaceutical Company Limited
Amgen Inc.
Boehringer Ingelheim International GmbH
Viatris Inc.
Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals Inc.
Sun Pharmaceutical Industries Limited
Genentech Inc.
Chiesi Farmaceutici S.p.A
Dr. Reddy's Laboratories Ltd
Cipla Ltd
Lupin Limited
Zydus Lifesciences Ltd.
ECU Health
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
소아천식 치료 시장 2029 : 새로운 기회를 제공하는 국가
소아천식 치료 시장 2029 : 새로운 기회를 제공하는 부문
소아천식 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Pediatric asthma treatment involves medical care and therapeutic approaches aimed at managing and alleviating asthma symptoms in children. This includes medications, lifestyle changes, and monitoring techniques to reduce inflammation, prevent asthma attacks, and enhance respiratory function.
The primary types of pediatric asthma treatment include long-term control medications, quick-relief medications, and other categories. Long-term control medications are drugs taken daily over a prolonged period to decrease inflammation, prevent symptoms, and maintain stable lung function. This group includes inhaled corticosteroids, long-acting beta agonists, leukotriene modifiers, antihistamines, and biologics. These medications are administered via various routes such as oral, nasal, and injectable. They are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are used in different settings including hospitals, clinics, home care, and other healthcare environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The pediatric asthma treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric asthma treatment market statistics, including pediatric asthma treatment global market size, regional shares, competitors with pediatric asthma treatment market share, detailed pediatric asthma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric asthma treatment industry. The pediatric asthma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric asthma treatment market size has grown strongly in recent years. It will grow from $11.03 billion in 2024 to $11.65 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth during the historic period can be attributed to the increasing incidence of childhood asthma, heightened awareness of respiratory disorders in children, a rise in air pollution and environmental allergens, growing healthcare spending on pediatric care, and awareness campaigns led by NGOs and healthcare organizations focused on asthma.
The pediatric asthma treatment market size is expected to see strong growth in the next few years. It will grow to $14.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth projected for the forecast period can be attributed to the rising prevalence of allergic disorders in children, the expansion of biologic therapies for severe pediatric asthma, increased investments in pediatric drug development, a growing focus on personalized and precision medicine, and the expanding middle-class population with access to private healthcare. Key trends expected during this period include the development of pediatric-friendly biologic therapies, creation of rapid allergen identification tools, integration of electronic health records, innovations in inhaler formulations, and advances in immunotherapy for asthma.
The rising prevalence of respiratory infections is expected to drive growth in the pediatric asthma treatment market going forward. Respiratory infections are illnesses caused by viruses, bacteria, or other pathogens that impact the respiratory tract, including the nose, throat, airways, and lungs. This increase is mainly attributed to rising air pollution, as exposure to pollutants like particulate matter and nitrogen dioxide weakens the respiratory system, making individuals more vulnerable to infections. Pediatric asthma treatments help reduce the frequency and severity of respiratory infections by improving airway function and decreasing inflammation, thereby lowering susceptibility to infectious triggers. For example, according to the Australian Institute of Health and Welfare, a government agency in Australia, chronic obstructive pulmonary disease accounted for 3.6% of the total disease burden and represented 50% of the total burden of respiratory conditions in 2023. Additionally, an estimated 638,000 people (2.5% of the population) in Australia were living with chronic obstructive pulmonary disease in 2022. Hence, the rising incidence of respiratory infections is fueling the growth of the pediatric asthma treatment market.
Key companies in the pediatric asthma treatment market are focusing on innovative therapies, such as monoclonal antibodies, to target and reduce airway inflammation in children. Monoclonal antibodies are laboratory-produced proteins designed to mimic the immune system's ability to combat harmful pathogens by specifically targeting certain cells or substances. For instance, in April 2024, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, received approval from the U.S. Food and Drug Administration for FASENRA (benralizumab) as an add-on maintenance treatment for children aged 6 to 11 years with severe asthma characterized by an eosinophilic phenotype. This antibody aims to reduce asthma exacerbations and improve symptom control by targeting and eliminating eosinophils. Fasenra is administered by subcutaneous injection once every four weeks for the first three doses, followed by once every eight weeks, with pediatric dosing adjusted according to body weight.
In January 2025, Molex LLC, a US-based consumer electronics company, acquired Vectura Group plc for an undisclosed sum. Through this acquisition, Molex LLC intends to expand its inhalation drug delivery capabilities and reinforce its position as a leading provider of comprehensive solutions for respiratory and non-respiratory therapies. Vectura Group Services Limited is a UK-based company developing a pediatric asthma treatment, a smart budesonide delivery system known as VR647.
Major players in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd., and ECU Health.
North America was the largest region in the pediatric asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric asthma treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pediatric asthma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric asthma treatment market consists of sales of nebulizers and soft-mist inhalers, oral medications, biologic injectables, and smart monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Asthma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pediatric asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pediatric asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric asthma treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Long-Term Control Medications; Quick-Relief Medications; Other Types
2) By Drug Class: Inhaled Corticosteroids; Long-Acting Beta Agonists; Leukotriene Modifiers; Antihistamines; Biologics
3) By Route Of Administration: Oral Route; Nasal Route; Injectable Route
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End User: Hospitals; Clinics; Home Care; Other End users
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids; Leukotriene Modifiers; Long-Acting Beta Agonists; Combination Inhalers; Biologic Therapies
2) By Quick-Relief Medications: Short-Acting Beta Agonists; Anticholinergics; Systemic Corticosteroids
3) By Other Types: Immunotherapy; Methylxanthines; Alternative Therapies
Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Amgen Inc.; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; Genentech Inc.; Chiesi Farmaceutici S.p.A; Dr. Reddy's Laboratories Ltd; Cipla Ltd; Lupin Limited; Zydus Lifesciences Ltd.; ECU Health.
3. Pediatric Asthma Treatment Market Trends And Strategies
4. Pediatric Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Pediatric Asthma Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Pediatric Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pediatric Asthma Treatment Market Growth Rate Analysis
5.4. Global Pediatric Asthma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pediatric Asthma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pediatric Asthma Treatment Total Addressable Market (TAM)
6. Pediatric Asthma Treatment Market Segmentation
6.1. Global Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-Term Control Medications
Quick-Relief Medications
Other Types
6.2. Global Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids
Long-Acting Beta Agonists
Leukotriene Modifiers
Antihistamines
Biologics
6.3. Global Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Route
Nasal Route
Injectable Route
6.4. Global Pediatric Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Pediatric Asthma Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care
Other End users
6.6. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids
Leukotriene Modifiers
Long-Acting Beta Agonists
Combination Inhalers
Biologic Therapies
6.7. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta Agonists
Anticholinergics
Systemic Corticosteroids
6.8. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunotherapy
Methylxanthines
Alternative Therapies
7. Pediatric Asthma Treatment Market Regional And Country Analysis
7.1. Global Pediatric Asthma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pediatric Asthma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pediatric Asthma Treatment Market
9.1. China Pediatric Asthma Treatment Market Overview
9.2. China Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pediatric Asthma Treatment Market
10.1. India Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pediatric Asthma Treatment Market
11.1. Japan Pediatric Asthma Treatment Market Overview
11.2. Japan Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pediatric Asthma Treatment Market
12.1. Australia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pediatric Asthma Treatment Market
13.1. Indonesia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pediatric Asthma Treatment Market
14.1. South Korea Pediatric Asthma Treatment Market Overview
14.2. South Korea Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pediatric Asthma Treatment Market
15.1. Western Europe Pediatric Asthma Treatment Market Overview
15.2. Western Europe Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pediatric Asthma Treatment Market
16.1. UK Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pediatric Asthma Treatment Market
17.1. Germany Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pediatric Asthma Treatment Market
18.1. France Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pediatric Asthma Treatment Market
19.1. Italy Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pediatric Asthma Treatment Market
20.1. Spain Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pediatric Asthma Treatment Market
21.1. Eastern Europe Pediatric Asthma Treatment Market Overview
21.2. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pediatric Asthma Treatment Market
22.1. Russia Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pediatric Asthma Treatment Market
23.1. North America Pediatric Asthma Treatment Market Overview
23.2. North America Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pediatric Asthma Treatment Market
24.1. USA Pediatric Asthma Treatment Market Overview
24.2. USA Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pediatric Asthma Treatment Market
26.1. South America Pediatric Asthma Treatment Market Overview
26.2. South America Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pediatric Asthma Treatment Market
27.1. Brazil Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pediatric Asthma Treatment Market
28.1. Middle East Pediatric Asthma Treatment Market Overview
28.2. Middle East Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pediatric Asthma Treatment Market
29.1. Africa Pediatric Asthma Treatment Market Overview
29.2. Africa Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pediatric Asthma Treatment Market Competitive Landscape And Company Profiles
